Answers are grounded in this paper and cite their sources.
Combination therapy improves tumor control and survival in advanced lung squamous cell carcinoma, suggesting further validation is needed.
The addition of BACE to chemotherapy and immunotherapy may improve tumor control and prolong progression-free survival in patients with advanced LUSC. These findings support the integration of BACE into combination treatment strategies and warrant further validation in prospective trials.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: